Patents by Inventor Laura A. Martinson

Laura A. Martinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6060640
    Abstract: A permeable structure forms a chamber to hold living cells. The structure includes a first permeable region surrounding at least a portion of the chamber having a conformation that, when implanted in host tissue, substantially blocks penetration of host cells into the chamber while permitting solute transport. The structure also includes a second permeable region overlying the first permeable region having a conformation that, when implanted in host tissue, forms a permeable interface with host tissue that permits solute transport. A third permeable region is located between the first and second permeable regions. The third region comprises a solution of polymer material formed in place between the first and second permeable regions. The third permeable region bonds the first and second permeable regions together. The third permeable region also has a conformation that, when implanted in host tissue, permits solute transport between the first and second permeable regions.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: May 9, 2000
    Assignee: Baxter International Inc.
    Inventors: Robin G. Pauley, Donna L. McLarty, Atul R. Khare, Shmuel Sternberg, Daniel R. Boggs, Steven Neuenfeldt, Mark Jones, James H. Brauker, Laura A. Martinson
  • Patent number: 5964804
    Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 12, 1999
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Robert C. Johnson, Laura A. Martinson, Ronald S. Hill
  • Patent number: 5882354
    Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 16, 1999
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Robert C. Johnson, Laura A. Martinson, Ronald S. Hill
  • Patent number: 5807406
    Abstract: Polymer membrane structures are microfabricated from polyimide film by lithography or etching. The microfabricated structures have systematically varied dimensions and geometries conducive to implanting in host tissue and the promotion, when implanted, of new vascular structures.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: September 15, 1998
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Laura A. Martinson, Shmuel Sternberg, David Bellamy
  • Patent number: 5800529
    Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 1, 1998
    Assignee: Baxter International, Inc.
    Inventors: James H. Brauker, Robert C. Johnson, Laura A. Martinson, Ronald S. Hill
  • Patent number: 5782912
    Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
    Type: Grant
    Filed: March 17, 1994
    Date of Patent: July 21, 1998
    Assignee: Baxter International, Inc.
    Inventors: James H. Brauker, Robert C. Johnson, Laura A. Martinson, Ronald S. Hill
  • Patent number: 5741330
    Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 21, 1998
    Assignee: Baxter International, Inc.
    Inventors: James H. Brauker, Robert C. Johnson, Laura A. Martinson, Ronald S. Hill
  • Patent number: 5593440
    Abstract: A method for implanting cells is disclosed which employs a chamber having a wall forming porous boundary between the host and implanted cells. According to the method, a given number of cells (N) is placed within the porous boundary of a given area (A) such that the quantity A/N is less than about 200 .mu.m.sup.2 /cell. The porous boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward.
    Type: Grant
    Filed: May 23, 1994
    Date of Patent: January 14, 1997
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Ronald S. Hill, Laura A. Martinson, Daniel R. Boggs, Robert C. Johnson
  • Patent number: 5569462
    Abstract: Methods for enhancing vascular support of cells housed within an implanted apparatus are disclosed. The methods comprise placing a population of therapeutic substance-producing cells into the cell receiving chamber of an immunoisolation apparatus, implanting the apparatus into a patient, and administering an immunomodulatory agent to the patient. The immunomodulatory agent increases the number of close vascular structures in the vicinity of the implanted device, which increases the long term survival of the cell population housed therein.
    Type: Grant
    Filed: March 31, 1995
    Date of Patent: October 29, 1996
    Assignee: Baxter International Inc.
    Inventors: Laura A. Martinson, James H. Brauker, Robert C. Johnson, Thomas Loudovaris
  • Patent number: 5314471
    Abstract: Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish a boundary between the host and the implanted cells. The boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward. The boundary allows the fabrication and clinical use of implant assemblies and methodologies that can carry enough cells to be of therapeutic value to the host, yet occupy a relatively small, compact area within the host.
    Type: Grant
    Filed: April 1, 1992
    Date of Patent: May 24, 1994
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Ronald S. Hill, Laura A. Martinson, Daniel R. Boggs, Robert C. Johnson